San Diego-based mostly Viking Therapeutics marked alone as a serious competitor within the weight loss drug market place in February immediately after revealing promising knowledge from the mid-stage trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when presented as a weekly injection As well